23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Nanochitosan antimicrobial activity against Streptococcus mutans and Candida albicans dual-species biofilms

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          Chitosan nanoparticle (nanochitosan) has a broad antimicrobial spectrum against diverse pathogenic microorganisms. However, its effect on dental caries-associated microorganisms, such as Streptococcus mutans and Candida albicans is yet to be explored. These microorganisms are known for causing early childhood caries. Therefore, this study was aimed at investigating nanochitosan inhibition capacity against dual-species biofilms of S. mutans and C. albicans. In this study, nanochitosan antimicrobial activity is reported against mono and dual biofilm species of S. mutans and/or C. albicans at 3 and 18 h incubation time. Nanochitosan inhibition capacity was observed through biofilm mass quantity and cell viability.

          Results

          The present study successfully synthesized nanochitosan with average diameter of approximately 20–30 nm, and also established dual-species biofilms of S. mutans and C. albicans in vitro. With nanochitosan treatment, the cell viability of both microorganisms significantly decreased with the increasing concentration of nanochitosan. There was no significant decrease in biofilm mass both in the dual and single-species biofilms after 3 h of incubation. However, greater inhibition of biofilm was observed at 18 h incubation.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found

          Antimicrobial properties of chitosan and mode of action: a state of the art review.

          Owing to its high biodegradability, and nontoxicity and antimicrobial properties, chitosan is widely-used as an antimicrobial agent either alone or blended with other natural polymers. To broaden chitosan's antimicrobial applicability, comprehensive knowledge of its activity is necessary. The paper reviews the current trend of investigation on antimicrobial activities of chitosan and its mode of action. Chitosan-mediated inhibition is affected by several factors can be classified into four types as intrinsic, environmental, microorganism and physical state, according to their respective roles. In this review, different physical states are comparatively discussed. Mode of antimicrobial action is discussed in parts of the active compound (chitosan) and the target (microorganisms) collectively and independently in same complex. Finally, the general antimicrobial applications of chitosan and perspectives about future studies in this field are considered. Copyright © 2010 Elsevier B.V. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Chitosan chemistry and pharmaceutical perspectives.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Biodegradation, biodistribution and toxicity of chitosan.

              Chitosan is a natural polysaccharide that has attracted significant scientific interest during the last two decades. It is a potentially biologically compatible material that is chemically versatile (-NH2 groups and various M(w)). These two basic properties have been used by drug delivery and tissue engineering scientists to create a plethora of formulations and scaffolds that show promise in healthcare. Despite the high number of published studies, chitosan is not approved by the FDA for any product in drug delivery, and as a consequence very few biotech companies are using this material. This review will aim to provide information on these biological properties that affect chitosan's safe use in drug delivery. The term "Chitosan" represents a large group of structurally different chemical entities that may show different biodistribution, biodegradation and toxicological profiles. Here we aim to review research in this area and critically discuss chitosan's potential to be used as a generally regarded as safe (GRAS) material. 2009 Elsevier B.V. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                +62-81281793504 , rikono@nano.or.id
                agniaani@gmail.com
                indra@sith.itb.ac.id
                kurniawan@nano.or.id
                wibias.muliawan@gmail.com
                boybachtiar@gmail.com
                etik.mardliyati@bppt.go.id
                endang04@ui.ac.id
                nurul@nano.or.id
                kagami@po.mdu.ac.jp
                li@po.mdu.ac.jp
                tokikoni@ims.u-tokyo.ac.jp
                a-tojo@ims.u-tokyo.ac.jp
                Journal
                BMC Res Notes
                BMC Res Notes
                BMC Research Notes
                BioMed Central (London )
                1756-0500
                8 July 2019
                8 July 2019
                2019
                : 12
                : 383
                Affiliations
                [1 ]Division of Bionanotechnology, Nano Center Indonesia, Tangerang Selatan, Indonesia
                [2 ]Department of Metallurgical Engineering, Sumbawa University of Technology, Sumbawa Besar, Indonesia
                [3 ]ISNI 0000 0001 2151 536X, GRID grid.26999.3d, Division of Molecular Therapy, , The Institute of Medical Science, University of Tokyo, ; Tokyo, Japan
                [4 ]ISNI 0000 0004 1808 0563, GRID grid.434933.a, School of Life Science and Technology, , Bandung Institute of Technology, ; Bandung, Indonesia
                [5 ]ISNI 0000000120191471, GRID grid.9581.5, Oral Science Laboratory, Department of Oral Biology, Faculty of Dentistry, , Universitas Indonesia, ; Jakarta, Indonesia
                [6 ]ISNI 0000 0001 0746 0534, GRID grid.432292.c, Center for Pharmaceutical and Medical Technology, , Agency for the Assessment and Application of Technology [BPPT], ; Tangerang Selatan, Indonesia
                [7 ]ISNI 0000 0004 0644 6054, GRID grid.249566.a, Research Center for Physics, , Indonesian Institute of Science [LIPI], ; Tangerang Selatan, Indonesia
                [8 ]ISNI 0000 0004 0372 3845, GRID grid.411611.2, Department of Oral and Maxillofacial Surgery, , Matsumoto Dental University, ; Shiojiri, Japan
                [9 ]ISNI 0000 0001 2151 536X, GRID grid.26999.3d, Department of General Medicine, IMSUT Hospital, The Institute of Medical Science, , University of Tokyo, ; Tokyo, Japan
                [10 ]ISNI 0000 0001 2151 536X, GRID grid.26999.3d, Department of Cell Processing and Transfusion, The Institute of Medical Science, , University of Tokyo, ; Tokyo, Japan
                Author information
                http://orcid.org/0000-0001-9368-8737
                Article
                4422
                10.1186/s13104-019-4422-x
                6613267
                31287001
                fc37b53e-fa47-49f0-8ec6-0e06c5d8be4f
                © The Author(s) 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 13 May 2019
                : 29 June 2019
                Funding
                Funded by: Japan Society for the Promotion of Science
                Award ID: ID no: R11525
                Award Recipient :
                Funded by: Grant-in-Aid for Scientific Research, JSPS Kakenhi
                Award ID: JP16H05546
                Award Recipient :
                Categories
                Research Note
                Custom metadata
                © The Author(s) 2019

                Medicine
                biofilm,candida albicans,caries,nanochitosan,streptococcus mutans
                Medicine
                biofilm, candida albicans, caries, nanochitosan, streptococcus mutans

                Comments

                Comment on this article